{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:20:38Z","timestamp":1790252438746,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["humanpathol.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.humpath.2017.08.015","type":"journal-article","created":{"date-parts":[[2017,8,26]],"date-time":"2017-08-26T16:45:18Z","timestamp":1503765918000},"page":"47-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma"],"prefix":"10.1016","volume":"68","author":[{"given":"Erika M.","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.","family":"Swerdlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2017.08.015_bb0005","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","year":"2008"},{"key":"10.1016\/j.humpath.2017.08.015_bb0010","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2017.08.015_bb0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/path.1485","article-title":"Differential emu enhancer activity and expression of BOB.1\/OBF.1, Oct 2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas","volume":"202","author":"Loddenkemper","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2017.08.015_bb0020","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/modpathol.2009.54","article-title":"Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers","volume":"22","author":"Nam-Cha","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2017.08.015_bb0025","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1309\/YCH8DWUFFQBKGPVB","article-title":"The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma","volume":"120","author":"Browne","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2017.08.015_bb0030","first-page":"1889","article-title":"European task force on lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes","volume":"96","author":"Anagnostopoulos","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2017.08.015_bb0035","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/blood.V97.2.496","article-title":"Down-regulation of BOB.1\/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription","volume":"97","author":"Stein","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2017.08.015_bb0040","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/modpathol.3800227","article-title":"Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma","volume":"17","author":"Garcia-Cosio","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2017.08.015_bb0045","first-page":"2080","article-title":"Oct-2 and bob-1 deficiency in Hodgkin and reed Sternberg cells","volume":"61","author":"Re","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2017.08.015_bb0050","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2559.2000.00830.x","article-title":"Varied B-cell immunophenotypes of Hodgkin\/Reed-Sternberg cells in classic Hodgkin's disease","volume":"36","author":"Watanabe","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2017.08.015_bb0055","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3324\/haematol.11523","article-title":"A clinicopathological study of B-cell differentiation markers and transcription factors in classical Hodgkin's lymphoma: a potential prognostic role of MUM1\/IRF4","volume":"92","author":"Valsami","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2017.08.015_bb0060","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.4049\/jimmunol.1400531","article-title":"Putting J chain back on the map: how might its expression define plasma cell development?","volume":"193","author":"Castro","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.humpath.2017.08.015_bb0065","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/ajcp\/86.3.292","article-title":"Reed-Sternberg and Hodgkin cells in lymphocyte predominant Hodgkin's disease of nodular subtype contain J chain","volume":"86","author":"Stein","year":"1986","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2017.08.015_bb0070","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/jcp.32.8.802","article-title":"Immunochemical demonstration of J chain: a marker of B-cell malignancy","volume":"32","author":"Isaacson","year":"1979","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2017.08.015_bb0075","first-page":"1281","article-title":"L and H cells of nodular lymphocyte predominant Hodgkin's disease show immunoglobulin light-chain restriction","volume":"139","author":"Schmid","year":"1991","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2017.08.015_bb0080","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1177\/28.8.6777426","article-title":"The diversity of the immunohistological staining pattern of Sternberg-reed cells","volume":"28","author":"Poppema","year":"1980","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.humpath.2017.08.015_bb0085","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1365-2559.2002.01338.x","article-title":"Immunohistochemical detection of CD30 remains negative in nodular lymphocyte predominant Hodgkin's disease using enhanced antigen retrieval","volume":"40","author":"Roberts","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2017.08.015_bb0090","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ni.2688","article-title":"MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B-cell lymphoma","volume":"14","author":"Ying","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.humpath.2017.08.015_bb0095","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00428-015-1796-6","article-title":"Pattern of MEF2B expression in lymphoid tissues and in malignant lymphomas","volume":"467","author":"Krenacs","year":"2015","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2017.08.015_bb0100","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1200\/JCO.2007.11.8869","article-title":"German Hodgkin Study G. Lymphocyte predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group","volume":"26","author":"Nogova","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2017.08.015_bb0105","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00000478-199405000-00014","article-title":"Nodular lymphocyte predominance Hodgkin's disease. A distinct clinicopathological entity","volume":"18","author":"Mason","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2017.08.015_bb0110","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.1999.17.3.776","article-title":"Clinical presentation, course, and prognostic factors in lymphocyte predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European task force on lymphoma project on lymphocyte predominant Hodgkin's disease","volume":"17","author":"Diehl","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2017.08.015_bb0115","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0002-9440(10)63027-1","article-title":"The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease","volume":"159","author":"Torlakovic","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2017.08.015_bb0120","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1073\/pnas.94.17.9337","article-title":"Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center\u2013derived tumor B-cells","volume":"94","author":"Braeuninger","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2017.08.015_bb0125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.seminhematol.2016.05.007","article-title":"Hodgkin lymphoma: pathology and biology","volume":"53","author":"Mathas","year":"2016","journal-title":"Semin Hematol"},{"key":"10.1016\/j.humpath.2017.08.015_bb0130","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/PAI.0000000000000107","article-title":"Diagnostic utility of the germinal center\u2013associated markers GCET1, HGAL, and LMO2 in hematolymphoid neoplasms","volume":"23","author":"Menter","year":"2015","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2017.08.015_bb0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2559.2012.04198.x","article-title":"Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody","volume":"61","author":"Agostinelli","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2017.08.015_bb0140","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1182\/blood-2007-06-094151","article-title":"Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas","volume":"111","author":"Montes-Moreno","year":"2008","journal-title":"Blood"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817717302964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817717302964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T08:36:26Z","timestamp":1535445386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817717302964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":28,"alternative-id":["S0046817717302964"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2017.08.015","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2017.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}